Biogen Inc. (BIIB)
NASDAQ: BIIB · IEX Real-Time Price · USD
229.93
-0.64 (-0.28%)
May 20, 2024, 11:42 AM EDT - Market open
Biogen Revenue
Biogen had revenue of $9.66B in the twelve months ending March 31, 2024, down -4.37% year-over-year. Revenue in the quarter ending March 31, 2024 was $2.29B, a -7.00% decrease year-over-year. In the year 2023, Biogen had annual revenue of $9.84B, a decrease of -3.32%.
Revenue (ttm)
$9.66B
Revenue Growth
-4.37%
P/S Ratio
3.47
Revenue / Employee
$1,276,499
Employees
7,570
Market Cap
33.51B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.84B | -337.80M | -3.32% |
Dec 31, 2022 | 10.17B | -808.30M | -7.36% |
Dec 31, 2021 | 10.98B | -2.46B | -18.32% |
Dec 31, 2020 | 13.44B | -933.30M | -6.49% |
Dec 31, 2019 | 14.38B | 925.00M | 6.88% |
Dec 31, 2018 | 13.45B | 1.18B | 9.61% |
Dec 31, 2017 | 12.27B | 825.10M | 7.21% |
Dec 31, 2016 | 11.45B | 685.00M | 6.36% |
Dec 31, 2015 | 10.76B | 1.06B | 10.93% |
Dec 31, 2014 | 9.70B | 2.77B | 39.97% |
Dec 31, 2013 | 6.93B | 1.42B | 25.66% |
Dec 31, 2012 | 5.52B | 467.83M | 9.27% |
Dec 31, 2011 | 5.05B | 332.21M | 7.04% |
Dec 31, 2010 | 4.72B | 339.08M | 7.75% |
Dec 31, 2009 | 4.38B | 279.84M | 6.83% |
Dec 31, 2008 | 4.10B | 925.89M | 29.19% |
Dec 31, 2007 | 3.17B | 488.57M | 18.21% |
Dec 31, 2006 | 2.68B | 260.55M | 10.76% |
Dec 31, 2005 | 2.42B | 210.94M | 9.54% |
Dec 31, 2004 | 2.21B | 1.53B | 225.62% |
Dec 31, 2003 | 679.18M | 274.96M | 68.02% |
Dec 31, 2002 | 404.22M | 131.55M | 48.24% |
Dec 31, 2001 | 272.68M | 118.00M | 76.28% |
Dec 31, 2000 | 154.68M | 36.68M | 31.08% |
Dec 31, 1999 | 118.00M | 31.04M | 35.70% |
Dec 31, 1998 | 86.96M | 42.35M | 94.95% |
Dec 31, 1997 | 44.61M | 14.60M | 48.64% |
Dec 31, 1996 | 30.01M | 6.37M | 26.96% |
Dec 31, 1995 | 23.64M | 16.19M | 217.56% |
Dec 31, 1994 | 7.44M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Centene | 155.52B |
Takeda Pharmaceutical | 28.16B |
Koninklijke Philips | 20.19B |
GE HealthCare Technologies | 19.50B |
Haleon | 14.31B |
ICON PLC | 8.23B |
ResMed | 4.58B |
Mettler-Toledo International | 3.79B |
BIIB News
- 3 days ago - Biogen and Ionis Pharma shares slide as they end development of ALS treatment - Market Watch
- 4 days ago - Biogen, Ionis to discontinue development of ALS drug - Reuters
- 4 days ago - Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis - GlobeNewsWire
- 4 days ago - Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis - PRNewsWire
- 5 days ago - Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status - GlobeNewsWire
- 18 days ago - Biogen Reports Progress on Corporate Responsibility Priorities - GlobeNewsWire
- 24 days ago - Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA® - GlobeNewsWire
- 26 days ago - Biogen Stock Rises After Earnings and on Jump in Alzheimer's Drug Sales - Barrons